The industry claims there is a blockade and a risk of unviability for Diverde; the APA defends the legal framework and accuses pharmaceutical companies of fueling public controversy.
Waste containing needles sparks standoff between APA and pharmaceutical companies
Friday, 10 April 2026RSS
